Lv7
5000 积分 2022-09-07 加入
Immune checkpoint inhibitors and cardiovascular toxicity
3个月前
已完结
Advances in Noninvasive Imaging of Natural Killer Cells
4个月前
已完结
124I Radiolabeled Basiliximab for CD25-Targeted Immuno-PET Imaging of Activated T Cells
4个月前
已完结
Peptide-Based Autophagic Gene and Cisplatin Co-delivery Systems Enable Improved Chemotherapy Resistance
7个月前
已完结
A nanovaccine targeting cancer stem cells and bulk cancer cells for postoperative cancer immunotherapy
7个月前
已完结
The current landscape of frontline large B-cell lymphoma trials
10个月前
已完结
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
10个月前
已完结
How I treat older patients with relapsed/refractory diffuse large B-cell lymphoma
10个月前
已完结
Quantitative PET tracking of intra-articularly administered 89Zr-peptide-decorated nanoemulsions
10个月前
已完结
Navigating the Evolving Treatment Landscape of Diffuse Large B-Cell Lymphoma
11个月前
已完结
皖公网安备34019202002308
